Synergistic Cancer Immunotherapy by Inducing Immunogenic Cell Death and Blocking the CD39-Adenosine Pathway Using a
Yiwen Liu1, Xiaoyu Pang2, Lin Li2
1Department of Otolaryngology-Head and Neck Surgery, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.
Pharmaceutics
|July 28, 2026
Summary
This study developed nanoparticles delivering chemotherapy and a CD39 inhibitor to combat the immunosuppressive tumor microenvironment. This combination therapy enhances anti-tumor immunity and inhibits cancer growth.
Area of Science:
- Nanotechnology
- Immunology
- Oncology
Background:
- The tumor microenvironment (TME) is immunosuppressive due to CD39 converting ATP to adenosine.
- This immunosuppression limits the effectiveness of cancer immunotherapy.
Purpose of the Study:
- To develop a nanoparticle (NP) platform for combined chemo-immunotherapy.
- To co-deliver an immunogenic cell death (ICD) inducer (doxorubicin) and a CD39 inhibitor (ARL67156).
Main Methods:
- Developed amphiphilic polymer-based NPs for drug delivery.
- Co-loaded NPs with doxorubicin (DOX) and ARL67156.
- Evaluated NP performance in vitro and in vivo for chemo-immunotherapy.
Main Results:
- NPs induced ICD and inhibited CD39 activity.
- Co-loaded NPs synergistically increased extracellular ATP and enhanced dendritic cell maturation.
- In vivo studies showed enhanced tumor accumulation, growth inhibition, and T-cell activation.
Conclusions:
- The developed nanoplatform effectively targets the ATP-adenosine axis.
- This approach amplifies ICD and reverses tumor immunosuppression.
- Presents a promising strategy for enhanced cancer immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...